help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 26, 2003, doi:10.1164/rccm.200211-1302OC

Am. J. Respir. Crit. Care Med., Volume 168, Number 5, September 2003, 594-600

A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200211-1302OCv1
168/5/594    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallace, H. L
Right arrow Articles by Southern, K. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, H. L
Right arrow Articles by Southern, K. W

Submitted on November 9, 2002
Accepted on June 25, 2003

Nasal airway ion transport and lung function in young people with Cystic Fibrosis

Helen L Wallace1*, Pierre M Barker2, and Kevin W Southern1

1 Institute of Child Health, University of Liverpool, Liverpool, Merseyside, United Kingdom, 2 Division of Pediatric Pulmonology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

* To whom correspondence should be addressed. E-mail: hwallace{at}liv.ac.uk.

There is strong evidence that abnormal airway ion transport is the primary defect that initiates the pathophysiology of lung disease in cystic fibrosis. To examine the relationship between airway ion transport abnormality and severity of lung disease, we measured nasal potential difference in 51 young people with cystic fibrosis using a validated modified technique. There was no correlation between any component of the ion transport measurement and clinical condition (respiratory function, chest radiograph score or Shwachman clinical score). 30 subjects, homozygous for the {Delta}F508 mutation, were divided into those above and those below average respiratory function for their age. There was no significant difference in any of the ion transport parameters between those with above and below average pulmonary function. Of the 51 subjects, 10 had significant hyperpolarization following perfusion with a zero Cl- solution (>5mV). This Cl- secretory capacity did not correlate with above average lung function. These data do not support the assertion that the extent of lung disease in cystic fibrosis reflects the degree of ion transport abnormality. We suggest that whilst an ion transport abnormality initiates lung disease, other factors (e.g environmental and genetic modifiers) are more influential in determining disease severity.


Key words: young people, nasal potential difference, chloride secretion, delta F508, FEV1




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
S. M. Rowe, F. Accurso, and J. P. Clancy
Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials
Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P G Noone and K W Southern
Unravelling salt transport in cystic fibrosis
Thorax, November 1, 2004; 59(11): 916 - 917.
[Full Text] [PDF]


Home page
ThoraxHome page
I Fajac, D Hubert, D Guillemot, I Honore, T Bienvenu, F Volter, J Dall'Ava-Santucci, and D J Dusser
Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients
Thorax, November 1, 2004; 59(11): 971 - 976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. B. Salinas, N. Pedemonte, C. Muanprasat, W. F. Finkbeiner, D. W. Nielson, and A. S. Verkman
CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L936 - L943.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
K W Southernl and D Peckham
Establishing a diagnosis of cystic fibrosis
Chronic Respiratory Disease, October 1, 2004; 1(4): 205 - 210.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Mekus, B. Tummler, K. W. Southern, H. L. Wallace, and P. M. Barker
Genes, Environment, Ion Transport, and Cystic Fibrosis
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 770 - 771.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  ATS Quiz on Sleep Study Tracings